Integra LifeSciences Reports Third Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/14/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Integra LifeSciences (IART) PT Raised to $52 at Truist Securities
October 26, 2022 4:54 PM EDTTruist Securities analyst Richard Newitter raised the price target on Integra LifeSciences (NASDAQ: IART) to $52.00 (from $46.00) while maintaining a Hold rating.
The analyst commented, "We still see IART in transition to its LT rev growth and margin goals, but IART's 3Q... More
